Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Melanoma 3Leukemia 3Congenital Abnormalities 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Neuroblastoma 2Neoplasms, Plasma Cell 2Myelodysplastic Syndromes 2Multiple Myeloma 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Leukemia, Myeloid, Accelerated Phase 2Graft vs Host Disease 2Carcinoma, Renal Cell 2Carcinoma, Ovarian Epithelial 2Breast Neoplasms 2Blast Crisis 2Uveal Melanoma 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Small Cell Lung Carcinoma 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Primary Myelofibrosis 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Osteosarcoma 1Optic Nerve Glioma 1Oligodendroglioma 1

Interventions

Cytarabine 23Busulfan 12Peripheral Blood Stem Cell Transplantation 11Cyclophosphamide 10fludarabine phosphate 9Filgrastim 9Cyclosporine 9Antilymphocyte Serum 9Idarubicin 8Methotrexate 7sargramostim 6Mitoxantrone 6Gemtuzumab 6Etoposide 6Daunorubicin 6Radiotherapy 5tipifarnib 4Whole-Body Irradiation 4alvocidib 3Vorinostat 3Tacrolimus 3Mycophenolic Acid 3Methylprednisolone 3Flow Cytometry 3Cytogenetic Analysis 3Cyclosporins 3Clofarabine 3Azacitidine 3merphos 2Topotecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Megakaryoblastic, Acute × Immunologic Techniques × Clear all
NCT00814164 2016-08-17

Clofarabine and Daunorubicin in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Roswell Park Cancer Institute

Phase 2 Terminated
21 enrolled 8 charts
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡